muscone has been researched along with Cardiovascular Stroke in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, Y; Li, W; Liu, J; Mao, T; Tang, Y; Wei, Y; Yang, S | 1 |
| Aa, N; Du, Y; Ge, Y; Gu, X; Lin, Z; Meng, H; Shi, J; Wang, X; Wu, X; Xu, Z; Yang, Z; Zhu, D; Zhuang, R | 1 |
| Chen, B; Chen, P; Gao, W; Lu, X; Meng, H; Tao, Z; Wang, L; Wang, X; Wang, ZM; Xu, Z; Yang, N; Yang, Z; Zhang, M; Zhou, N; Zhu, T | 1 |
| Li, L; Li, Y; Zhang, J | 1 |
| Li, LD; Li, XR; Li, YK; Ma, K; Pan, L; Wu, LM; Zhang, JY; Zhang, YT | 2 |
6 other study(ies) available for muscone and Cardiovascular Stroke
| Article | Year |
|---|---|
Muscone attenuates susceptibility to ventricular arrhythmia by inhibiting NLRP3 inflammasome activation in rats after myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Connexin 43; Fibrosis; Inflammasomes; Inflammation; Myocardial Infarction; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Signal Transduction | 2023 |
Hypoxia-Inducible Factor 1 alpha (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Pathway Participates in Angiogenesis of Myocardial Infarction in Muscone-Treated Mice: Preliminary Study.
Topics: Angiogenesis Inducing Agents; Animals; Cycloparaffins; Disease Models, Animal; Echocardiography; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Neovascularization, Pathologic; Neovascularization, Physiologic; Preliminary Data; Vascular Endothelial Growth Factor A; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Beneficial effects of muscone on cardiac remodeling in a mouse model of myocardial infarction.
Topics: Animals; Body Weight; Cardiotonic Agents; Cycloparaffins; Disease Models, Animal; Fibrosis; Gene Expression; Heart Ventricles; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; NF-kappa B; Nitric Oxide Synthase Type III; Organ Size; Physical Conditioning, Animal; Physical Endurance; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Ventricular Function, Left; Ventricular Remodeling | 2014 |
Comparison of the therapeutic effects of different compositions of muskone in the treatment of experimental myocardial infarct in rats and analgesia in mice.
Topics: Analgesics; Animals; Cycloparaffins; In Situ Nick-End Labeling; Mice; Myocardial Infarction; Pain; Rats | 2008 |
[Study on comparative pharmacology of series of Muskone].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aristolochia; Cycloparaffins; Drug Combinations; Drugs, Chinese Herbal; Endothelins; Female; Inula; Male; Mice; Mice, Inbred ICR; Myocardial Infarction; Pain; Plants, Medicinal; Rats; Rats, Wistar; Thromboxane B2 | 2006 |
[Study on therapeutic effects of series of muskone on myocardial infarction canines].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aristolochia; Cycloparaffins; Dogs; Drug Combinations; Drugs, Chinese Herbal; Endothelins; Female; Inula; Male; Myocardial Infarction; Myocardium; Plants, Medicinal; Thromboxane B2 | 2006 |